ReviewCurrent hypertension reports2026
Orthostatic Hypertension: Clinical Spectrum and Gaps in Knowledge.
Review in Current hypertension reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewOrthostatic hypertension (oHT) is increasingly recognized as a clinically relevant but poorly understood disorder of autonomic blood pressure control. This review aims to summarize the current understanding of the clinical spectrum and pathophysiology of oHT, evaluate its prognostic significance, and identify key gaps in knowledge to guide future mechanistic and clinical studies. RECENT
findingsRecent evidence has shifted the perception of oHT from a physiological variant to a condition associated with adverse outcomes. In younger adults, oHT has been linked to incident hypertension, while in older populations it is associated with cardiovascular, cerebrovascular, renal, and cognitive complications. Excessive sympathetically mediated vasoconstriction appears to be the predominant mechanism, although arterial stiffness, impaired baroreflex buffering, and abnormal vascular responsiveness may also contribute depending on the population. Consensus definitions have recently standardized diagnostic criteria, but uncertainties remain regarding optimal thresholds, measurement reproducibility, and the mechanisms underlying its heterogeneous presentation. Despite growing recognition, important questions remain regarding whether oHT represents an independent cardiovascular risk factor or primarily a marker of vascular aging and hypertension. Evidence supporting oHT-specific therapeutic strategies is currently lacking. Further research is needed to clarify its pathophysiology, refine diagnostic approaches, and determine its clinical and prognostic significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.